InvestorsHub Logo
Followers 18
Posts 1919
Boards Moderated 0
Alias Born 12/13/2009

Re: kund post# 461973

Friday, 06/21/2024 2:05:21 PM

Friday, June 21, 2024 2:05:21 PM

Post# of 483512

It's a feel-good factor for management; they need some work to appear busy by following OLE sites



What a revelation--thanks much. I need to immediately contact SAVA's management and that of numerous other biotech companies and ask them why they are wasting a lot of shareholder money with open label extension programs. Shame on SAVA for caving to over 700 patients requests (90% of those who have completed a Phase III study) and currently offering Simufilam at over 100 clinical sites.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News